baber/WOPTO huggingface dataset:
Patent NZ-514592-A (NZ)
Title: Formulation arrays and use thereof
Inventor: GALAKATOS NICHOLAS
IPC: A61K47/34
Filed: 2000-03-31
Abstract: An array of multiple liquid formations of a known compound, wherein: a) said known compound is a pharmaceutical, agricultural, or veterinary product, b) the formulations are located at separate sites or in separate wells, c) each formulation comprises a different mixture of at least two materials having known functions, activities or properties, each mixture varying in the concentration or composition of at least one material, and wherein one of said at least two materials is said known compound, d) the array is comprised of more than 1000 different formulations, e) the array is formed by input of the materials at separate sites from multiple sources under the control of an automatic processor, and f) wherein the array can be connected to or accessed by means for screening each formulation for at least one variable relating to intended function, activity, chemical or physical properties.
Patent NZ-517432-A (NZ)
Title: Process for coating thermoplastic substrates with a coating composition containing a non-aggressive solvent
Inventor: O'NEIL JAMES WILLIAM
IPC: C08J7/043
Filed: 2000-10-04
Abstract: A  process  for  coating  a  thermoplastic  substrate comprises  applying a solvent based coating  composition  to the  substrate and curing the coating composition at ambient temperature  to 125oC to form a uniform smooth film  on  the substrate. The coating composition comprises 45-80% by weight of a film forming  binder  and 20-55% by weight of an  organic  liquid carrier. The  binder consists of: (A) 40-90% by weight, based on  the weight  of  the binder, of a polymer consisting  of  acrylic polyol, polyester polyol, polyether polyol or a polyurethane polyol; and (B) 10-60% by weight, based on the weight of the binder, of an organic polyisocyanate crosslinking agent. The  organic  liquid carrier used in the coating composition consists  of at least 50% by weight, based on the weight  of the  organic liquid carrier used in the coating composition, of  tertiary butyl acetate and up to 50% by weight, based on the   weight  of  the  organic  liquid  carrier,  of   other compatible organic solvent.
Patent NZ-518579-A (NZ)
Title: Use of 5HT3 agonists for relaxing the fundus-a cause of gastrointestinal disorder
Inventor: MEULEMANS ANN LOUISE GABRIELLE
IPC: A61K31/4045
Filed: 2000-11-20
Abstract: Use  of a compound having 5HT3 agonistic activity  for restoring  an  impaired relaxation of  the  fundus  to  food ingestion (a gastrointestinal disorder).
Patent NZ-519649-A (NZ)
Title: Detection of patheogenic organisms using the P3 and/or P19 hypervariable region(s) of the RNase P RNA gene as a diagnostic target
Inventor: HERRMANN BJORN
IPC: C12Q1/68
Filed: 2001-01-10
Abstract: A method for detection of pathogenic organisms is described wherein the method includes differentiation between species. The method is especially suitable to detect and to diagnose infection by pathogenic organisms that are hard and/or laborious to detect with conventional methods. The method relies upon analysis of specific variable regions of the RNase P RNA gene, namely the P3 and/or P19 variable region(s).
Patent NZ-521523-A (NZ)
Title: 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
Inventor: VAILLANCOURT VALERIE A
IPC: A61P15/00
Filed: 2001-03-15
Abstract: Described are 4-hydroxy-1,8-naphthyridine-3-carboxamide compounds of formula IV, for which the substituents are described herein. The compounds are used in the manufacture of medicaments for treating viral infection.
Patent NZ-523001-A (NZ)
Title: Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
Inventor: GERONI MARIA CRISTINA ROSA
IPC: A61K31/513
Filed: 2001-06-20
Abstract: Disclosed is a pharmaceutical composition comprising a pharmaceutically acceptable carrier or excipient and, as active ingredient, a) a compound of formula (I) wherein: R1 is bromine or chlorine; and R2 is a distamycin or distamycin-like framework; and b) an antimetabolite. The pharmaceutical composition described above is useful in the treatment of tumours by way of prevention or treatment of metastasis or inhibition of angiogenesis. In particular tumours of the breast, ovary, lung, colon, kidney, stomach, pancreas, liver, skin, brain and leukaemia are disclosed.
Patent NZ-523231-A (NZ)
Title: A so-called transport peptide module known as moving functioning as a transport peptide module to which cargo can be attached
Inventor: LANGEDIJK JOHANNES PETRUS MARI
IPC: A61K39/00
Filed: 2001-06-28
Abstract: Described are peptides derived from or similar to the Erns protein of pestiviruses for type -specific diagnosis of infection, for eliciting antibiotic activity and for transport of substances into a cell. For these purposes among others an isolated, synthetic or recombinant protein module or functional equivalent thereof comprising an amino acid sequence that is at least 70% identical to an amino acid sequence of a peptide located from at about amino acid position 194 to 220 in a pestiviral Erns protein is provided. Figure 1 is a schematic representation of alignment of pestivirus Erns with RNase Rh, which indicates the modular organisation of Erns. Erns consists of an RNase domain (dotted) and a C-terminal membrane active domain (filled black). The C-terminal domain (residues 191-227) that shows resemblance to the L3 loop of cytotoxic RNases is also described. RNase active site domains are shown as chequered boxes. Potential glycosylation sites are shown as ellipses.
Patent NZ-523355-A (NZ)
Title: A hook
Inventor: KING JOHN BLAKELY
IPC: E06B11/06
Filed: 2002-12-23
Abstract: A hook comprising a handle portion and an attachment portion, where the attachment portion comprises of at least one coil having at least two adjacent coil portions. The adjacent coil portions are shaped to form a guide way for a catch. The guide way is internal to one of the coil portion and also external to the other coil portion. The catch retained in the attachment portion when it rests in the said guide way.
Patent NZ-533703-A (NZ)
Title: Method for detecting human papillomavirus mRNA
Inventor: KARLSEN FRANK
IPC: G01N33/50
Filed: 2003-01-07
Abstract: An in vitro method of screening human subjects to assess their risk of developing cervical carcinoma comprises: The screening of the subject for expression of mRNA transcripts of the E6 gene of HPV and sorting the subject into one of two categories of risk for development of cervical carcinoma based on expression of E6 mRNA; The individuals positive for expression of E6 mRNA are scored as carrying integrated HPV or a modified episomal HPV genome and are therefore classified as high risk for development of cervical carcinoma; The individuals with negative expression of E6 mRNA are scored as not carrying integrated HPV or modified episomal HPV genome and are therefore not classified as no detectable risk for development of cervical carcinoma; The screening for E6 mRNA expression is carried out using the isothermal amplification in combination with real-time detection of the amplification product. Also described is the use of primer-pairs which enable amplification of a region of E6 transcripts from HPV types 16, 18, 31 and 33 by NASBA and one or more molecular beacon probes in the manufacture of a kit for detecting mRNA transcripts of the E6 gene(s) of HPV.
Patent NZ-535322-A (NZ)
Title: Range sensing system
Inventor: CARNEGIE DALE ANTHONY
IPC: G01S17/10
Filed: 2004-09-13
Abstract: A method and apparatus for determining the velocity of a target are disclosed. A light energy source is activated in a cyclic pattern of a selected frequency. A receiver operates in conjunction with a shielding system configured to block the sensing of light energy reflected from the target in a cyclic pattern with a selected receiver frequency. By measuring a change in the source frequency when received at the receiver a velocity component of the target in a known direction may be calculated. Two or three dimensional velocity vectors may be calculated through the addition of further light energy sources.
Patent NZ-536099-A (NZ)
Title: Melanocortin receptor ligands
Inventor: EBETINO FRANK HALLOCK
IPC: C07D211/16
Filed: 2003-04-16
Abstract: Compounds comprising a 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring. The compounds, including all enantiomeric and diasteriomeric forms and pharmaceutically acceptable salts thereof, have the following formula:
Patent NZ-537004-A (NZ)
Title: N-benzoylureidocinnamate derivatives, method for production and use thereof
Inventor: SCHOENAFINGER KARL
IPC: C07C/
Filed: 2003-05-22
Abstract: N-benzoylureidocinnamic acid derivatives of formula (I), the physiologically acceptable salts and method for production thereof are disclosed, wherein R1-R11 are as defined in the specification. These compounds are suitable as an anti-diabetic agent.
Patent NZ-538709-A (NZ)
Title: Genetic analysis and authentication
Inventor: HASHMI GHAZALA
IPC: C12Q1/68
Filed: 2003-09-04
Abstract: A composition for analyzing a target nucleic acid sequence obtained or derived from a patient genomic sample and for identifying the patient providing the sample. The composition comprises: a first set of oligonucleotide for identifying the target nucleic acid sequence obtained or derived from the patient sample; a second set of oligonucleotide for identifying marker sequences, wherein the marker sequences are derived from subsequences in the patient genomic sample, the subsequences each including at least one polymorphic marker, the identification of the marker providing for identification of the patient, wherein the oligonucleotides of the first and the second set are attached to beads that are associated with a chemically or physically distinguishable characteristic that identifies the oligonucleotides attached to the beads. Also described is a method for analyzing a target nucleic sequence obtained or derived from a patient genomic sample and for identifying the patient providing the sample, comprising the steps: (a) providing a first set of oligonucleotides for identifying the target nucleic acid sequence obtained or derived from the patient sample; (b) a second set of oligonucleotides for identifying marker sequences that are derived from subsequences each including at least one polymorphic marker, the identification of the marker sequences providing for the identification of the patient, wherein the first and second set of oligonucleotides are attached to beads that are associated with a chemical or physically distinguishable characteristic that identifies the oligonucleotides attached to the beads; (c) contacting the target sequence
Patent NZ-542619-A (NZ)
Title: Preparation of high viscosity beta-glucan concentrates
Inventor: VASANTHAN THAVARATNAM
IPC: C12P19/04
Filed: 2004-03-19
Abstract: A method of concentrating beta-glucans (BG) from a flour comprising the steps of: a) mixing a flour and a 40-100% (w/w) aqueous alcohol to form a flour/aqueous alcohol slurry; b) separating some protein and starch from the slurry to create a fiber residue having a reduced starch and protein content from the flour/aqueous-alcohol slurry, wherein the fiber residue has a higher BG content than the flour; c) subjecting the fiber residue from step b) to at least one additional treatment step, the additional treatment step including mixing the fiber residue from step b) with an aqueous alcohol to form a fiber residue/aqueous-alcohol slurry and subjecting the fiber residue/aqueous-alcohol slurry to a sonication, protease or amylase treatment step or a combination of a sonication, protease or amylase treatment step and thereafter separating a final fiber residue from the fiber residue/aqueous-alcohol slurry and wherein the alcohol in steps a) and c) is 40-100% w/w.
Patent NZ-545161-A (NZ)
Title: Building panels to provide panel formwork for concrete walls.
Inventor: EMBLIN ALAN GAYNE
IPC: E04B1/16
Filed: 2004-08-25
Abstract: A building system is described comprising paired studs (20) for attachment to inside surfaces of facing sheets (10, 11) to provide panel formwork for concrete walls. The studs comprise a head (21) and outwardly extending spaced flanges (22, 23) with inwardly directed teeth (26) and lips (24, 25). Spacer elements (30) are engaged with the recess between the flanges and may be formed from off-cuts of sheet material or as specifically formed elements. The latter are formed from hard plastic and in a preferred embodiment (19) are formed as a rectangular box which can be orientated in alternate directions. The system may include end elements (40), internal top and bottom plates (51), internal corners (90), external corners (100) and a shadow line junction between panels. The invention extends to panels formed with the above system and buildings formed from the panels.
Patent NZ-545900-A (NZ)
Title: Plumbing fitting
Inventor: SOUTHEN ANDREW WILLIAM
Filed: 2006-03-14
Abstract: A plumbing fitting (Fig. 8 embodiment) has an inlet pipe 821 connectable to a water supply 2 such as a wall elbow, an outlet 822 connectable to an appliance, and a valve 820 between the inlet pipe and the outlet that can be moved to allow or cut off water flow between the inlet pipe and the outlet. No part of the fitting extends beyond the profile of the inlet pipe. In embodiments such as Fig.3 the outlet of the fitting is taken to be the threaded socket 522a into which the outlet pipe 522 is screwed, so the outlet of the fitting itself does not extend beyond the profile of the inlet pipe!
Patent NZ-548877-A (NZ)
Title: Blade for fluid turbine with free end having arcuate face and aerodynamic fin formed on back face
Inventor: EMSHEY GARRY
IPC: F03D9/34
Filed: 2006-08-01
Abstract: A blade for a fluid turbine has a first end for connection to a rotor of a turbine and a second free end having an arcuate face and an aerodynamic fin formed on a back surface extending the full distance of the second free end.
Patent NZ-552693-A (NZ)
Title: Retro-fit responsible gaming system
Inventor: XIDOS JOHN
IPC: G06F19/00
Filed: 2005-06-16
Abstract: A responsible gaming system (90) enabling networked gaming devices to be retrofit to operate as a responsible gaming system in order to allow or deny player access to a local gaming device on a gaming network in accordance with player exclusion criteria is disclosed. The networked gaming devices have an existing central system (20) for managing the networked gaming devices that remains unmodified after being retrofit with the responsible gaming system. The responsible gaming system comprises: a central management module (50) for, independently of the existing central system, receiving, storing, and processing identity data relating to individual players enrolled with the system, gaming data relating to gaming activities of the individual players using the system and player account information. The central management module is retro-fit to the networked gaming devices without affecting data collection functions of the existing central system. The responsible gaming system further comprises a player management console (30) for operative and retro-fit connection to a local gaming device (10) by a flow through data connection and the central management module. The player management console includes an input device for receiving identity data from a player, and communicating player identity data to the central management module only; the player management console also for communicating gaming data to the central management module and for controlling access to the local gaming device in response to approval by the central management module. The player management console further includes a display for providing a player with player account information received from the central management module. The central management module provides instructions to the player management console to enable activation or cause de-activation of a local gaming device in accordance with pre-determined player exclusion criteria; and the existing central system remains unmodified after being retrofit with the responsible gaming system.
Patent NZ-567717-A (NZ)
Title: Methods for treating interleukin-6 related diseases
Inventor: OKUDA OSAMU
IPC: A61P35/00
Filed: 2004-04-28
Abstract: Disclosed is the use of an anti-IL-6 receptor antibody for the preparation of a medicament for the treatment of IL-6 related diseases (wherein said IL-6 related diseases are rheumatoid arthritis, plasmacytosis, hyperimmunoglobulinemia, anemia, nephritis, cachexia, multiple myeloma, Castleman's disease, mesangial proliferative nephritis, systemic lupus erythematosus, Crohn's disease, pancreatitis, psoriasis, juvenile idiopathic arthritis or systematic juvenile idiopathic arthritis), wherein the medicament is for administration at a dosage of the anti-IL-6 receptor antibody of 4mg/kg/4 weeks or more, or the dosage showing the anti-IL-6 receptor antibody concentration in blood equivalent thereto. Also disclosed is the use of an anti-IL-6 receptor antibody for the preparation of a medicament for reduction or prevention of allergic reactions upon the treatment of IL-6 related diseases, wherein the medicament is for administration at a dosage of the anti-IL-6 receptor antibody of· 4mg/kg/4 weeks or more, or the dosage showing an anti-IL-6 receptor antibody concentration in blood equivalent thereto.
Patent NZ-568421-A (NZ)
Title: Therapeutically active alpha-MSH analogues
Inventor: JONASSEN THOMAS ENGELBRECHT NORKILD
IPC: A61K38/34
Filed: 2005-08-26
Abstract: Disclosed are peptide analogues of a-melanocyte-stimulating hormone (a-MSH), which posses an increased efficacy compared to the native a-MSH peptide. The a-MSH analogues exhibit increased anti-inflammatory effects and increased capability to prevent ischemic conditions compared to a-MSH. Further disclosed is the use of the peptides for the manufacture of pharmaceutical compositions for the treatment or prophylaxis of a condition in the tissue of one or more organs of a mammal, and moreover pharmaceutical compositions. (62) Divided Out of 566489
Patent NZ-569225-A (NZ)
Title: Method of dispensing liquid from a bottle with inert gas shielding
Inventor: YOSHIDA EIJI
IPC: B67D1/00
Filed: 2003-05-23
Abstract: To dispense wine from a bottle B the bottle stopper is replaced with a down flow valve 64 in a nitrogen atmosphere. The down flow valve includes a hollow portion 62 to be press fitted in the head portion of the bottle and a discharge valve capable of advancing and retreating in the hollow portion relative to the valve body and biased toward the closed position. The wine from the bottle flows down into the airtight storage chamber 65 that is filled with nitrogen gas from source 85 when the down flow valve is opened, then the down flow valve is closed and the extraction valve 70 is opened so that the wine can flow down into the glass via nozzle 74. When the wine from the bottle is stored in the airtight chamber 65 for dispensing via the extraction valve, the air within the storage body is first removed by displacing the air with nitrogen gas. In this way the wine in the bottle and in the storage chamber is never contaminated by the oxygen gas of the ambient air.
Patent NZ-575524-A (NZ)
Title: A slider for a slide fastener where the diamond has a cavity to assist in maintaining dimentional stability during cooling
Inventor: PEANO ROBERTO
IPC: B22D30/00
Filed: 2009-03-13
Abstract: A slider (5) for a slide fastener is disclosed. The slider (5) has a structure with an upper blade (10), a lower blade (11), lateral flanges and a diamond (20) connecting the upper (10) and lower blades (11). The diamond (20) has a blind cavity (21) with the opening in the lower blade (11). The cavity sides (22) are of substantially constant thickness and parallel to the external faces of the diamond (20). The cavity (21) assists to maintain the dimensional stability of the slider (5) when cooling down after casting.
Patent NZ-578130-A (NZ)
Title: Genetic products differentially expressed in tumors and the use thereof
Inventor: SAHIN UGUR
IPC: A61K39/00
Filed: 2003-11-21
Abstract: Disclosed is a pharmaceutical composition, comprising one or more components selected from the group consisting of: (i) a tumour-associated antigen or a functional fragment thereof; (ii) a nucleic acid which codes for a tumour-associated antigen or a functional fragment thereof; (iii) an antibody which binds to a tumour-associated antigen or a functional fragment thereof; (iv) an antisense nucleic acid which hybridizes specifically with a nucleic acid coding for a tumour associated antigen; (v) an isolated host cell which expresses a tumour associated antigen or a functional fragment thereof; and (vi) isolated complexes between a tumour-associated antigen or a functional fragment thereof and an HLA molecule. The tumour-associated antigen disclosed in (i)-(vi) has a sequence encoded by a nucleic acid which is selected from the group consisting of: a) a nucleic acid which comprises a nucleic acid sequence selected from the group consisting of SEQ ID NO: 84, as defined in the specification, a fragment thereof, wherein said fragment thereof encodes a functional fragment of the tumour-associated antigen encoded by the nucleic acid sequence, b) a nucleic acid which hybridizes with the nucleic acid of a) under stringent conditions, c) a nucleic acid which is degenerate with respect to the nucleic acid of a) or b), and d) a nucleic acid which is complementary to the nucleic acid of a), b) or c).
Patent NZ-578886-A (NZ)
Title: Cleaning compositions comprising alpha-galactosidase from trichoderma reesei
Inventor: MACDONALD HUGH C
IPC: C11D3/386
Filed: 2008-02-26
Abstract: Discloses a cleaning composition comprising an isolated alpha-galactosidase enzyme comprising an amino acid sequence that is at least about 90% identical to an alpha-galactosidase of Trichoderma reesei, wherein said cleaning composition is suitable for at least partially removing a non-starch food polysaccharide from an object. Further disclosed is a cleaning method comprising contacting an isolated alpha-galactosidase enzyme comprising an amino acid sequence that is at least about 90% identical to an alpha-galactosidase of Trichoderma reesei, with an object under conditions suitable for activity of said alpha-galactosidase enzyme, to at least partially clean a non-starch food polysaccharide from said object.
Patent NZ-580042-A (NZ)
Title: Ibandronate sodium polymorphs
Inventor: DEVARAKONDA SURYA NARAYANA
IPC: C07F9/38
Filed: 2008-04-18
Abstract: A crystalline form of ibandronate sodium having an X-ray powder diffraction pattern with peaks at about 5.5, 10.9, 19.3, 23.1, and 33.2, ±0.2 degrees two theta; and a process for preparing said crystalline form of ibandronate sodium is disclosed, wherein the process comprises the steps of: (a) providing a solution of ibandronate sodium in formic acid, optionally in a mixture with methyl tertiary-butyl ether;(b) heating the solution to temperatures of 45 Deg. C to about 65 Deg. C;(c) adding methyl tertiary-butyl ether;(d) separating a solid; and (e) converting the solid of step (d) into the crystalline form of ibandronate sodium.